Latest Insider Transactions at Foghorn Therapeutics Inc. (FHTX)
This section provides a real-time view of insider transactions for Foghorn Therapeutics Inc. (FHTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Foghorn Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Foghorn Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
857
-100.0%
|
$8,570
$10.17 P/Share
|
|
Sep 23
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
857
+50.0%
|
$2,571
$3.72 P/Share
|
|
Sep 20
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
35,756
-100.0%
|
$357,560
$10.04 P/Share
|
|
Sep 20
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,756
+50.0%
|
$107,268
$3.72 P/Share
|
|
Sep 18
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
11,574
-100.0%
|
$115,740
$10.05 P/Share
|
|
Sep 18
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,574
+50.0%
|
$34,722
$3.72 P/Share
|
|
Sep 17
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
10,272
-100.0%
|
$102,720
$10.04 P/Share
|
|
Sep 17
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,272
+50.0%
|
$30,816
$3.72 P/Share
|
|
Sep 16
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
400
-100.0%
|
$4,000
$10.0 P/Share
|
|
Sep 16
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+50.0%
|
$1,200
$3.72 P/Share
|
|
Sep 09
2024
|
Steven F. Bellon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.4%
|
$180,000
$9.5 P/Share
|
|
Mar 11
2024
|
Fanny Cavalie Chief Strategy/Bus Ops Officer |
SELL
Open market or private sale
|
Direct |
11,000
-12.64%
|
$66,000
$6.56 P/Share
|
|
Aug 17
2023
|
Adrian Gottschalk Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
63,000
+10.96%
|
-
|
|
Aug 17
2023
|
Adrian Gottschalk Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
63,000
-100.0%
|
-
|
|
Aug 16
2023
|
Samuel Agresta Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
311,297
-100.0%
|
$2,490,376
$8.25 P/Share
|
|
Aug 16
2023
|
Samuel Agresta Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
311,297
+50.0%
|
$933,891
$3.72 P/Share
|
|
May 26
2023
|
Adrian Gottschalk Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
300,000
+40.07%
|
-
|
|
May 26
2023
|
Adrian Gottschalk Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
300,000
-40.07%
|
-
|
|
Feb 17
2023
|
Adrian Gottschalk Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
184,939
+29.19%
|
-
|
|
Feb 17
2023
|
Adrian Gottschalk Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
184,939
-29.19%
|
-
|
|
Feb 17
2023
|
Adrian Gottschalk Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
4,371
+0.96%
|
-
|
|
Feb 17
2023
|
Adrian Gottschalk Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
4,371
-6.49%
|
-
|
|
Oct 25
2022
|
Adrian Gottschalk Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
4,371
-0.97%
|
-
|
|
Oct 25
2022
|
Adrian Gottschalk Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
4,371
+6.09%
|
-
|
|
Sep 16
2022
|
Adrian Gottschalk Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+17.66%
|
$0
$0.54 P/Share
|
|
Sep 13
2022
|
Simba Gill |
SELL
Bona fide gift
|
Direct |
47,939
-58.46%
|
-
|
|
Sep 12
2022
|
Simba Gill |
BUY
Exercise of conversion of derivative security
|
Direct |
82,000
+50.0%
|
$0
$0.73 P/Share
|
|
Aug 11
2022
|
Steven F. Bellon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,858
+1.5%
|
$5,574
$3.72 P/Share
|
|
May 25
2022
|
Steven F. Bellon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,392
+1.79%
|
$8,784
$2.23 P/Share
|
|
Feb 10
2022
|
Adrian Gottschalk Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
123,479
+21.58%
|
-
|
|
Feb 10
2022
|
Adrian Gottschalk Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
123,479
-84.3%
|
-
|
|
Dec 14
2021
|
Cigall Kadoch |
SELL
Bona fide gift
|
Direct |
333,333
-53.05%
|
-
|
|
Dec 09
2021
|
Carl Decicco Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104,310
+22.34%
|
$312,930
$3.72 P/Share
|
|
Aug 20
2021
|
Adrian Gottschalk Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+4.9%
|
$0
$0.54 P/Share
|
|
Aug 09
2021
|
Allan Reine Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,892
+33.33%
|
$80,676
$3.72 P/Share
|
|
Oct 27
2020
|
Adrian Gottschalk Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,225
+50.0%
|
-
|
|
Oct 27
2020
|
Carl Decicco Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
5,500
+2.08%
|
$88,000
$16.0 P/Share
|
|
Oct 27
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+2.14%
|
$2,400,000
$16.0 P/Share
|
|
Oct 27
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
12,524,120
+38.34%
|
-
|
|
Oct 27
2020
|
Investment Authority Abu Dhabi |
BUY
Open market or private purchase
|
Direct |
150,000
+10.86%
|
$2,400,000
$16.0 P/Share
|
|
Oct 27
2020
|
Investment Authority Abu Dhabi |
BUY
Conversion of derivative security
|
Direct |
1,081,081
+50.0%
|
-
|